Cargando…

Optimized haemostasis in nephron-sparing surgery using small-intestine submucosa

BACKGROUND: The indications for nephron-sparing surgery are expanding constantly. One major contributing fact for this development is the improvement of haemostatic techniques following excision of the tumor. Nevertheless, postoperative bleeding complications still occur. To prevent this, we prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Jörg, de Petriconi, Robert, Meilinger, Michael, Hautmann, Richard E, Bartsch, Georg
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386496/
https://www.ncbi.nlm.nih.gov/pubmed/18445250
http://dx.doi.org/10.1186/1471-2490-8-8
_version_ 1782155245699203072
author Simon, Jörg
de Petriconi, Robert
Meilinger, Michael
Hautmann, Richard E
Bartsch, Georg
author_facet Simon, Jörg
de Petriconi, Robert
Meilinger, Michael
Hautmann, Richard E
Bartsch, Georg
author_sort Simon, Jörg
collection PubMed
description BACKGROUND: The indications for nephron-sparing surgery are expanding constantly. One major contributing fact for this development is the improvement of haemostatic techniques following excision of the tumor. Nevertheless, postoperative bleeding complications still occur. To prevent this, we prospectively studied the effect of application of small-intestine submucosa (SIS) over the renal defect. METHODS: We performed 55 nephron-sparing surgeries applying SIS between 08/03 and 10/06 in 53 pts. (mean age: 59 yrs., range 29 – 79 yrs.). After resection of the renal tumor and application of a haemostyptic agent, we used SIS to secure and apply compression on the defect. RESULTS: The final pathology revealed clear-cell and papillary carcinoma, papillary adenoma, oncocytoma, and angiomyolipoma in 39 (70.9%), 6 (10.9), 1 (1.8%), 2 (3.6%) and 7 (12.7%) patients, respectively. The 45 malignant lesions (81.8%) were classified as pT1a and pT1b in 35 (77.8%) and 10 (22.2%) patients, respectively. The median tumor size was 4.5 cm (range: 1.3 – 13 cm). The median operating time was 186 min (range: 90 – 260 min). 18 (32.7%) procedures were performed without ischemia. 23 (41.8%) and 14 (25.5%) cases were operated in in-situ cold and warm ischemia, respectively. The median intraoperative blood loss was 730 cc (range: 100 – 2500 cc). No open operative revision was indicated due to postoperative bleeding complications. Furthermore, there was no necessity to substitute persistent blood loss from the drains postoperatively. No urinoma occurred. CONCLUSION: SIS is a highly effective and easy-to-use instrument for preventing postoperative bleeding and urinary fistula complications in nephron-sparing surgery.
format Text
id pubmed-2386496
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23864962008-05-16 Optimized haemostasis in nephron-sparing surgery using small-intestine submucosa Simon, Jörg de Petriconi, Robert Meilinger, Michael Hautmann, Richard E Bartsch, Georg BMC Urol Research Article BACKGROUND: The indications for nephron-sparing surgery are expanding constantly. One major contributing fact for this development is the improvement of haemostatic techniques following excision of the tumor. Nevertheless, postoperative bleeding complications still occur. To prevent this, we prospectively studied the effect of application of small-intestine submucosa (SIS) over the renal defect. METHODS: We performed 55 nephron-sparing surgeries applying SIS between 08/03 and 10/06 in 53 pts. (mean age: 59 yrs., range 29 – 79 yrs.). After resection of the renal tumor and application of a haemostyptic agent, we used SIS to secure and apply compression on the defect. RESULTS: The final pathology revealed clear-cell and papillary carcinoma, papillary adenoma, oncocytoma, and angiomyolipoma in 39 (70.9%), 6 (10.9), 1 (1.8%), 2 (3.6%) and 7 (12.7%) patients, respectively. The 45 malignant lesions (81.8%) were classified as pT1a and pT1b in 35 (77.8%) and 10 (22.2%) patients, respectively. The median tumor size was 4.5 cm (range: 1.3 – 13 cm). The median operating time was 186 min (range: 90 – 260 min). 18 (32.7%) procedures were performed without ischemia. 23 (41.8%) and 14 (25.5%) cases were operated in in-situ cold and warm ischemia, respectively. The median intraoperative blood loss was 730 cc (range: 100 – 2500 cc). No open operative revision was indicated due to postoperative bleeding complications. Furthermore, there was no necessity to substitute persistent blood loss from the drains postoperatively. No urinoma occurred. CONCLUSION: SIS is a highly effective and easy-to-use instrument for preventing postoperative bleeding and urinary fistula complications in nephron-sparing surgery. BioMed Central 2008-04-29 /pmc/articles/PMC2386496/ /pubmed/18445250 http://dx.doi.org/10.1186/1471-2490-8-8 Text en Copyright © 2008 Simon et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Simon, Jörg
de Petriconi, Robert
Meilinger, Michael
Hautmann, Richard E
Bartsch, Georg
Optimized haemostasis in nephron-sparing surgery using small-intestine submucosa
title Optimized haemostasis in nephron-sparing surgery using small-intestine submucosa
title_full Optimized haemostasis in nephron-sparing surgery using small-intestine submucosa
title_fullStr Optimized haemostasis in nephron-sparing surgery using small-intestine submucosa
title_full_unstemmed Optimized haemostasis in nephron-sparing surgery using small-intestine submucosa
title_short Optimized haemostasis in nephron-sparing surgery using small-intestine submucosa
title_sort optimized haemostasis in nephron-sparing surgery using small-intestine submucosa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386496/
https://www.ncbi.nlm.nih.gov/pubmed/18445250
http://dx.doi.org/10.1186/1471-2490-8-8
work_keys_str_mv AT simonjorg optimizedhaemostasisinnephronsparingsurgeryusingsmallintestinesubmucosa
AT depetriconirobert optimizedhaemostasisinnephronsparingsurgeryusingsmallintestinesubmucosa
AT meilingermichael optimizedhaemostasisinnephronsparingsurgeryusingsmallintestinesubmucosa
AT hautmannricharde optimizedhaemostasisinnephronsparingsurgeryusingsmallintestinesubmucosa
AT bartschgeorg optimizedhaemostasisinnephronsparingsurgeryusingsmallintestinesubmucosa